Teva Pharmaceutical Industries Comprehensive Income 2010-2025 | TEVA
Teva Pharmaceutical Industries comprehensive income for the quarter ending March 31, 2025 was $-2.675B, a 3.6% decline year-over-year.
- Teva Pharmaceutical Industries comprehensive income for 2024 was $-3.148B, a 16.72% increase from 2023.
- Teva Pharmaceutical Industries comprehensive income for 2023 was $-2.697B, a 4.97% decline from 2022.
- Teva Pharmaceutical Industries comprehensive income for 2022 was $-2.838B, a 5.78% increase from 2021.